骨科指南

订阅

MedSci主页 / 所有栏目 / 骨科指南

2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）

2019-08-22 美国风湿病学会 Arthritis Rheumatol. 2019 Aug 22.

强直性脊柱炎非放射学中轴型脊柱关节炎

2019年8月，美国风湿病学会(ACR)联合美国脊柱炎协会(SAA)更新发布了强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗指南建议，是对上一版管理建议的更新。文章针对强直性脊柱炎和非放射学中轴型脊柱关节炎管理中的新药以及轴向影像学检查的相关内容提出了指导建议。

中文标题：

2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）

英文标题：

2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.

发布机构：

美国风湿病学会

发布日期：

2019-08-22

简要介绍：

2019年8月，美国风湿病学会(ACR)联合美国脊柱炎协会(SAA)更新发布了强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗指南建议，是对上一版管理建议的更新。文章针对强直性脊柱炎和非放射学中轴型脊柱关节炎管理中的新药以及轴向影像学检查的相关内容提出了指导建议。

 

拓展指南：与强直性脊柱炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=c13211c001e88089, title=2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）, enTitle=2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis., guiderFrom=Arthritis Rheumatol. 2019 Aug 22., authorId=null, author=, summary=2019年8月，美国风湿病学会(ACR)联合美国脊柱炎协会(SAA)更新发布了强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗指南建议，是对上一版管理建议的更新。文章针对强直性脊柱炎和非放射学中轴型脊柱关节炎管理中的新药以及轴向影像学检查的相关内容提出了指导建议。 , cover=, journalId=null, articlesId=null, associationId=528, associationName=美国风湿病学会, associationIntro=The American College of Rheumatology&#039;s mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR&#039;s educational offerings., copyright=0, guiderPublishedTime=Thu Aug 22 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年8月，美国风湿病学会(ACR)联合美国脊柱炎协会(SAA)更新发布了强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗指南建议，是对上一版管理建议的更新。文章针对强直性脊柱炎和非放射学中轴型脊柱关节炎管理中的新药以及轴向影像学检查的相关内容提出了指导建议。</P> <P> </P>拓展指南：<strong>与<font color=red>强直性脊柱炎</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=0f3961c001a63043" title="风湿免疫疾病超药品说明书用药专家共识(之三)—强直性脊柱炎" target=_blank>风湿免疫疾病超药品说明书用药专家共识(之三)—强直性脊柱炎</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=923581c001a629e4" title="解读2015年美国风湿病学会强直性脊柱炎和放射学阴性中轴型脊柱关节炎新的治疗推荐" target=_blank>解读2015年美国风湿病学会强直性脊柱炎和放射学阴性中轴型脊柱关节炎新的治疗推荐</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=dfdf21c001365e28" title="风湿免疫疾病超药品说明书用药专家共识之三—强直性脊柱炎" target=_blank>风湿免疫疾病超药品说明书用药专家共识之三—强直性脊柱炎</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5b95b1c0013163a4" title="2016 NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）" target=_blank>2016 NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=354d01c000985597" title="依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议(2013)" target=_blank>依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议(2013)</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E5%BC%BA%E7%9B%B4%E6%80%A7%E8%84%8A%E6%9F%B1%E7%82%8E" target=_blank>有关强直性脊柱炎更多指南</a></ul>, tagList=[TagDto(tagId=1546, tagName=强直性脊柱炎), TagDto(tagId=94092, tagName=非放射学中轴型脊柱关节炎)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24435, appHits=769, showAppHits=0, pcHits=8915, showPcHits=18120, likes=127, shares=27, comments=9, approvalStatus=1, publishedTime=Thu Sep 05 00:40:02 CST 2019, publishedTimeString=2019-08-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 05 00:40:02 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 23:59:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）)])
2019 ACR/SAA建议：强直性脊柱炎和非放射学中轴型脊柱关节炎的治疗（更新版）
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2194828, encodeId=fcc8219482877, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=074a5306073, createdName=14878bb7m51(暂无昵称), createdTime=Sat Mar 23 10:47:21 CST 2024, time=2024-03-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1011251, encodeId=ef1c101125145, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80cb5584362, createdName=缓慢前进, createdTime=Wed Aug 25 09:42:41 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964629, encodeId=14a89646295d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3f5498206, createdName=ms8000000105310478, createdTime=Tue May 11 16:32:02 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961058, encodeId=78cf961058e4, content=有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5436898, createdName=ms3000001500460852, createdTime=Tue Apr 27 22:07:51 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957278, encodeId=ddf595e2787e, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK3lABlfDHXpqy4A6AhsoI8qGlVgbmQqZ38aX0hiap9nNHbWLLNhiar5OGumwKnTjZ12yzZNUO0Ra5w/0, createdBy=f5512106489, createdName=ms7155280995327310, createdTime=Thu Apr 15 14:40:53 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2024-03-23 14878bb7m51(暂无昵称) 来自上海

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194828, encodeId=fcc8219482877, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=074a5306073, createdName=14878bb7m51(暂无昵称), createdTime=Sat Mar 23 10:47:21 CST 2024, time=2024-03-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1011251, encodeId=ef1c101125145, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80cb5584362, createdName=缓慢前进, createdTime=Wed Aug 25 09:42:41 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964629, encodeId=14a89646295d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3f5498206, createdName=ms8000000105310478, createdTime=Tue May 11 16:32:02 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961058, encodeId=78cf961058e4, content=有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5436898, createdName=ms3000001500460852, createdTime=Tue Apr 27 22:07:51 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957278, encodeId=ddf595e2787e, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK3lABlfDHXpqy4A6AhsoI8qGlVgbmQqZ38aX0hiap9nNHbWLLNhiar5OGumwKnTjZ12yzZNUO0Ra5w/0, createdBy=f5512106489, createdName=ms7155280995327310, createdTime=Thu Apr 15 14:40:53 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-08-25 缓慢前进

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2194828, encodeId=fcc8219482877, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=074a5306073, createdName=14878bb7m51(暂无昵称), createdTime=Sat Mar 23 10:47:21 CST 2024, time=2024-03-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1011251, encodeId=ef1c101125145, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80cb5584362, createdName=缓慢前进, createdTime=Wed Aug 25 09:42:41 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964629, encodeId=14a89646295d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3f5498206, createdName=ms8000000105310478, createdTime=Tue May 11 16:32:02 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961058, encodeId=78cf961058e4, content=有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5436898, createdName=ms3000001500460852, createdTime=Tue Apr 27 22:07:51 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957278, encodeId=ddf595e2787e, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK3lABlfDHXpqy4A6AhsoI8qGlVgbmQqZ38aX0hiap9nNHbWLLNhiar5OGumwKnTjZ12yzZNUO0Ra5w/0, createdBy=f5512106489, createdName=ms7155280995327310, createdTime=Thu Apr 15 14:40:53 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-05-11 ms8000000105310478

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2194828, encodeId=fcc8219482877, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=074a5306073, createdName=14878bb7m51(暂无昵称), createdTime=Sat Mar 23 10:47:21 CST 2024, time=2024-03-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1011251, encodeId=ef1c101125145, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80cb5584362, createdName=缓慢前进, createdTime=Wed Aug 25 09:42:41 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964629, encodeId=14a89646295d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3f5498206, createdName=ms8000000105310478, createdTime=Tue May 11 16:32:02 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961058, encodeId=78cf961058e4, content=有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5436898, createdName=ms3000001500460852, createdTime=Tue Apr 27 22:07:51 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957278, encodeId=ddf595e2787e, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK3lABlfDHXpqy4A6AhsoI8qGlVgbmQqZ38aX0hiap9nNHbWLLNhiar5OGumwKnTjZ12yzZNUO0Ra5w/0, createdBy=f5512106489, createdName=ms7155280995327310, createdTime=Thu Apr 15 14:40:53 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-27 ms3000001500460852

    有中文版就更好了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2194828, encodeId=fcc8219482877, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=074a5306073, createdName=14878bb7m51(暂无昵称), createdTime=Sat Mar 23 10:47:21 CST 2024, time=2024-03-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1011251, encodeId=ef1c101125145, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80cb5584362, createdName=缓慢前进, createdTime=Wed Aug 25 09:42:41 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964629, encodeId=14a89646295d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a3f5498206, createdName=ms8000000105310478, createdTime=Tue May 11 16:32:02 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961058, encodeId=78cf961058e4, content=有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5436898, createdName=ms3000001500460852, createdTime=Tue Apr 27 22:07:51 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957278, encodeId=ddf595e2787e, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEK3lABlfDHXpqy4A6AhsoI8qGlVgbmQqZ38aX0hiap9nNHbWLLNhiar5OGumwKnTjZ12yzZNUO0Ra5w/0, createdBy=f5512106489, createdName=ms7155280995327310, createdTime=Thu Apr 15 14:40:53 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
    2021-04-15 ms7155280995327310

    谢谢

    0

相关指南

风湿免疫疾病超药品说明书用药专家共识之三—强直性脊柱炎

广东省药学会 · 2016-12-12

2016 NICE技术评估指南：Secukinumab用于非甾体类抗炎药或TNF抑制剂治疗后强直性脊柱炎活动期的治疗（TA407）

暂未更新 · 2016-09-28

2016 BSR/BHPR指南：生物制剂治疗中轴脊椎关节炎（包括强制性脊柱炎）

英国风湿病学会(BSR,British Society for Rheumatology) · 2016-08-29

依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议(2013)

中国风湿免疫科相关专家小组（统称） · 2013-05-14

2012 强直性脊柱炎的诊断与治疗骨科专家共识

中国骨科相关专家小组（统称） · 2012-09-01

2011 NICE 强直性脊柱炎--戈利木单抗用药指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-08-24